Open AccessPostoperative Bio-Chemoradiotherapy Using Cetuximab and Docetaxel in Patients With Cis-Platinum–Intolerant Core High-Risk Head and Neck Cancer: Protocol of a Phase 2 Nonrandomized Clinical Trial
Author(s) -
Goshi Nishimura,
Hyōe Hatakeyama,
Osamu Shiono,
Masataka Taguri,
Masanori Komatsu,
Daisuke Sano,
Naoko Sakuma,
Kenichiro Yabuki,
Yasuhiro Arai,
Kunihiko Shibata,
Yoshihiro Chiba,
Tetsuya Tanabe,
Nobuhiko Oridate
Publication year - 2018
Publication title -
jmir research protocols
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.378
H-Index - 9
ISSN - 1929-0748
DOI - 10.2196/11003
Subject(s) - cetuximab , medicine , docetaxel , head and neck cancer , oncology , chemoradiotherapy , clinical trial , protocol (science) , head and neck , radiation therapy , cancer , surgery , pathology , colorectal cancer , alternative medicine